Symrise Ag · XETR:SY1
Symrise — Symrise Ag Ord — Q1 2026 Earnings Presentation
19 slides from Symrise's earnings presentation, Apr 29, 2026
Slide 1: Trading Statement Q1 2026
Trading Statement Q1 2026 — Dr. Jean-Yves Parisot (CEO), Olaf Klinger (CFO) April 29, 2026
Slide 2: Agenda
Agenda — 1 2 3 Q1 2026 Strategy 2026 Review Execution Outlook Dr. Jean-Yves Parisot, CEO Update Olaf Klinger, CFO 2
Slide 3: Q1 2026 Review
01 Q1 2026 Review 3
Slide 4: Q1 2026 Highlights
Q1 2026 Highlights Q1 2026 REVIEW Strong execution in Q1 fueling reinvestment and continued ONE SYM Transformation acceleration — 1 Q1 with year-on-year organic sales decline of 0.4%, stronger than anticipated Positioning for further organizational evolution; accelerating significant structural cost
Slide 5: Q1 2026 Sales Performance
Q1 2026 Sales Performance Q1 2026 REVIEW Organic sales stronger-than-anticipated, driven by F&B, Pet and Fragrance — Group Taste, Nutrition & Health Scent & Care In €m In €m In €m -0.4% -0.1% -4.6% -5.2% 1,317 1,249 -5 -2 +1.7% -0.2% -5.4% -3.9% -3.4% 0.0% -3.6% -7.0% -61 779 749 13 -2 -42 538 500 -
Slide 6: Q1 2026 Sales by Region
Q1 2026 Sales by Region Q1 2026 REVIEW Solid growth in Americas and Asia Pacific — Organic sales growth by region Sales by region % of global sales 22% 24% North America +1.9% €1,249m Asia Pacific 14% EAME +3.4% -4.9% 40% Latin America NA LATAM EAME APAC +2.8% Note: see glossary for definitions. 6
Slide 7: Q1 2026 Execution Highlights
Q1 2026 Execution Highlights Q1 2026 REVIEW Investing and delivering value-added innovations to enable customer success — Pet Food Opened New Facility in Querétaro, Mexico • Enhances ability to support local pet food customers and meet growing demand Taste, • Utilizes best-in-class technologies and
Slide 8: Strategy Execution Update
02 Strategy Execution Update 8
Slide 9: ONE SYM Transformation: Momentum Building in Phase 2
ONE SYM Transformation: Momentum Building in Phase 2 STRATEGY EXECUTION UPDATE Reinvesting cost savings to unlock organic growth opportunities PLANNED ACTIVE COMPLETED Phase 3: Future Phase 2: Q2 2025 Drive Momentum & Activate & Start Delivering Deliver Performance Phase 1: April 2024 – Q1 2025 in a
Slide 10: Accelerating Phase Execution
Accelerating Phase 2 Execution STRATEGY EXECUTION UPDATE Providing the foundation for long-term top-line growth through targeted reinvestment ONE SYM Transformation - Phase 2: Activate & Start Delivering in a Structured Way Define Ambition and Set Validate and Prepare Implement Measures Ongoing Dire
Slide 11: Focus Areas for Decisive Action
Focus Areas for Decisive Action STRATEGY EXECUTION UPDATE Enhance Competitiveness and Accelerate Growth Our Focus Areas (2026 – 2028) Our Priorities Focusing resources on high-impact, scalable innovation bets – prioritizing Deliver Differentiated Innovation high-growth markets and right-to-win perfo
Slide 12: 2026 Outlook
03 2026 Outlook 12
Slide 13: Reaffirming FY 2026 Outlook and Mid-Term Targets
Reaffirming FY 2026 Outlook and Mid-Term Targets 2026 OUTLOOK — 2026 Outlook Mid-Term Targets (2025-2028) Organic growth 2%-4% 5%-7% (CAGR) EBITDA margin 21.5%-22.5% (Adjusted) 21%-23% BFCF margin >14% (Adjusted) >14% Commentary • Impact of Middle East conflict expected to remain • Multi-year growth
Slide 14: Closing Remarks
Closing Remarks Controlling the controllables while executing ONE Symrise Strategy and — accelerating multi-year ONE SYM Transformation 1 2 3 Enhance Drive durable, Increase competitiveness profitable growth shareholder value through the across all our through durable acceleration of the businesses
Slide 15: Symrise AG Contact
Symrise AG — Financial calendar Contact 06 May Symrise AG AGM 2026 Muehlenfeldstraße 1 37603 Holzminden, Germany 30 July Half Year Results 2026 René Weinberg Investor Relations 28 October rene.weinberg@symrise.com Q3 Trading Statement 2026 This document contains forward-looking statements, which are
Slide 16: Appendix
Appendix 16
Slide 17: Glossary
Glossary — APAC Asia Pacific BFCF Business Free Cash Flow DD Double digit EAME Europe, Africa, Middle East FX Foreign exchange HSD High single digit LATAM Latin America LSD Low single digit LTM Last twelve months MSD Mid single digit NA North America OSG Organic sales growth 17
Slide 18: Restatements related to Business transfer from TN&H to S&C
Restatements related to Business transfer from TN&H to S&C 2025 restated for the creation of Care & Wellness — 2025 Q1 QTD Q2 QTD H1 YTD Q3 QTD 9M YTD Q4 QTD FY 2025 Group Actual Restated Delta Actual Restated Delta Actual Restated Delta Actual Restated Delta Actual Restated Delta Actual Restated De
Slide 19: Slide 19